GMJ Briefs
What Patients Should Know: Three Key Advantages of the Experimental Diabetes Pill
Three key advantages distinguish the new diabetes pill: direct muscle activation, muscle mass preservation, and early safety data supporting its…
Medical Image Processing Speed Increases 10,000-Fold with New FireANTs Algorithm
New FireANTs algorithm achieves 10,000-fold speed improvement in medical image analysis while maintaining complete diagnostic accuracy.
Synthetic Cooling Compounds in E-Cigarettes Linked to Cardiac Arrhythmias
Laboratory study reveals synthetic cooling ingredients in e-cigarettes cause abnormal heart rhythms in both animal and human cellular models.
What the EV-D68 Vaccine Breakthrough Means for Pediatric Infection Prevention
EV-D68 vaccine research demonstrates immune protection through targeted viral blocking, with clear clinical need based on documented outbreak patterns since…
Study Reveals Dramatic Pain Relief Gap: Mitochondrial Therapy Outperforms Conventional Medications
Mitochondrial transplant therapy achieves 78% pain reduction versus 34% for standard medications in Duke University study of neuropathic pain treatment.
Stanford Develops Blood Test to Measure Biological Age Across 11 Organ Systems
New Stanford blood test measures biological age of 11 organ systems and predicts disease risk years in advance.
What Clinicians Should Know About the New Oral GLP-1 Option
Oral GLP-1 trial results suggest new treatment options may improve patient compliance and expand obesity therapy access.
Three Critical Healthcare Benefits from UK’s Pharmaceutical Licensing Expansion
UK pharmaceutical licensing expansion delivers improved medicine availability, stronger distribution networks, and enhanced national pharmaceutical security for healthcare providers.